• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[2013年至2022年云南省肿瘤医院15967例肺癌手术患者临床流行病学特征分析]

[Analysis of Clinical Epidemiological Characteristics of 15,967 Lung Cancer Surgery Patients in Yunnan Cancer Hospital from 2013 to 2022].

作者信息

Tang Ruke, Lei Yujie, Ye Lianhua, Zhao Guangqiang, Xiang Xudong, Li Gaofeng, Li Guangjian, Wang Xi, Chen Ying, Yang Kaiyun, Chen Xiaobo, Yang Jiapeng, Zhao Min, Xiang Bingquan, Huang Qiubo, Luo Guangcan, Zhang Hongwei, Huang Yunchao

机构信息

Department of Thoracic Surgery I, Yunnan Cancer Hospital, Kunming 650118, China.

Department of Thoracic Surgery II, Yunnan Cancer Hospital, Kunming 650118, China.

出版信息

Zhongguo Fei Ai Za Zhi. 2024 Dec 20;27(12):911-918. doi: 10.3779/j.issn.1009-3419.2024.101.33.

DOI:10.3779/j.issn.1009-3419.2024.101.33
PMID:39962846
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11839495/
Abstract

BACKGROUND

Lung cancer is a disease with a high incidence rate in Yunnan province, yet there is a paucity of large-scale studies on its clinical epidemiology. This research aims to investigate the epidemiological characteristics of patients who underwent lung cancer surgery at Yunnan Cancer Hospital over the past decade, thereby providing a theoretical basis for the prevention and treatment of lung cancer.

METHODS

Clinical data were collected from 15,967 patients who underwent lung cancer surgery at Yunnan Cancer Hospital between 2013 and 2022. A statistical analysis was conducted on the patients' general data, surgical information, pathological types of lung cancer, and other clinical epidemiological characteristics.

RESULTS

Among the 15,967 cases of lung cancer, 46.3% were male and 53.7% were female, with the male-to-female ratio ranging from 0.68 to 1.61:1. The median age was 56 years (interquartile range: 49-63), and 37.0% of the patients were in the age group of 50-59 years. Since 2017, there has been an annual increase in the proportion of patients under the age of 60 years. The smoking status of the patients showed that 28.1% were smokers and 71.9% were non-smokers. Qujing city accounted for 41.4% and Kunming city for 23.2% of the cases in Yunnan province, with 29.6% of patients originating from Xuanwei and Fuyuan areas of Qujing city. The distribution of affected lung lobes was as follows: right upper lobe 28.2%, right middle lobe 6.3%, right lower lobe 20.1%, left upper lobe 22.7%, and left lower lobe 16.4%. The use of thoracoscopic surgery increased from 30.8% to 96.3%, with single-port thoracoscopic surgery comprising 61.3%. Lobectomy was performed in 64.2% of cases, wedge resection in 17.2%, and segmentectomy in 12.2%. The proportion of lobectomy decreased from 83.1% to 46.1%. The proportion of patients in stages 0-I increased from 43.5% to 82.8%, while stages II-IV decreased from 56.5% to 17.2%. Adenocarcinoma increased from 75.6% to 88.3%, and squamous cell carcinoma decreased from 21.5% to 8.6%. Among adenocarcinoma patients, 60.9% were female. Among sguamous cell carcinoma patients, 90.6% were male. The peak age for adenocarcinoma was 50-59 years, and for squamous cell carcinoma, it was 60-69 years. The smoking rate was higher among squamous cell carcinoma patients (65.9%) compared to adenocarcinoma patients (22.3%). Adenocarcinoma patients had a higher proportion in stages 0-I (76.3%), while squamous cell carcinoma patients were more prevalent in stages II-III (64.1%).

CONCLUSIONS

The findings indicate an increasing proportion of female patients with adenocarcinoma, a younger age of onset, a higher proportion of non-smoking lung cancer patients, and an increased proportion of stages 0-I lung cancer. These trends may reflect the epidemiological characteristics of patients undergoing lung cancer surgery in Yunnan and surrounding areas over the past decade.

摘要

背景

肺癌是云南省发病率较高的疾病,但关于其临床流行病学的大规模研究较少。本研究旨在调查过去十年在云南省肿瘤医院接受肺癌手术患者的流行病学特征,从而为肺癌的防治提供理论依据。

方法

收集2013年至2022年期间在云南省肿瘤医院接受肺癌手术的15967例患者的临床资料。对患者的一般资料、手术信息、肺癌病理类型及其他临床流行病学特征进行统计分析。

结果

在15967例肺癌病例中,男性占46.3%,女性占53.7%,男女比例为0.68至1.61:1。中位年龄为56岁(四分位间距:49 - 63岁),37.0%的患者年龄在50 - 59岁之间。自2017年以来,60岁以下患者的比例逐年增加。患者的吸烟状况显示,28.1%为吸烟者,71.9%为非吸烟者。曲靖市占云南省病例的41.4%,昆明市占23.2%,29.6%的患者来自曲靖市宣威和富源地区。患侧肺叶分布如下:右上叶28.2%,右中叶6.3%,右下叶20.1%,左上叶22.7%,左下叶16.4%。胸腔镜手术的使用率从30.8%增至96.3%,其中单孔胸腔镜手术占61.3%。64.2%的病例进行了肺叶切除术,17.2%进行了楔形切除术,12.2%进行了肺段切除术。肺叶切除术的比例从83.1%降至46.1%。0 - I期患者的比例从43.5%增至82.8%,而II - IV期从56.5%降至17.2%。腺癌从75.6%增至88.3%,鳞状细胞癌从21.5%降至8.6%。腺癌患者中60.9%为女性。鳞状细胞癌患者中90.6%为男性。腺癌的发病高峰年龄为50 - 59岁,鳞状细胞癌为60 - 69岁。鳞状细胞癌患者的吸烟率(65.9%)高于腺癌患者(22.3%)。腺癌患者在0 - I期的比例较高(76.3%),而鳞状细胞癌患者在II - III期更为常见(64.1%)。

结论

研究结果表明,腺癌女性患者比例增加、发病年龄年轻化、非吸烟肺癌患者比例升高以及0 - I期肺癌患者比例增加。这些趋势可能反映了过去十年云南及周边地区接受肺癌手术患者的流行病学特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0361/11839495/3b213110fd8f/zgfazz-27-12-911-img_4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0361/11839495/4dcb68ce5419/zgfazz-27-12-911-img_1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0361/11839495/1c56de7d029c/zgfazz-27-12-911-img_2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0361/11839495/b433cf1a5faa/zgfazz-27-12-911-img_3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0361/11839495/3b213110fd8f/zgfazz-27-12-911-img_4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0361/11839495/4dcb68ce5419/zgfazz-27-12-911-img_1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0361/11839495/1c56de7d029c/zgfazz-27-12-911-img_2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0361/11839495/b433cf1a5faa/zgfazz-27-12-911-img_3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0361/11839495/3b213110fd8f/zgfazz-27-12-911-img_4.jpg

相似文献

1
[Analysis of Clinical Epidemiological Characteristics of 15,967 Lung Cancer Surgery Patients in Yunnan Cancer Hospital from 2013 to 2022].[2013年至2022年云南省肿瘤医院15967例肺癌手术患者临床流行病学特征分析]
Zhongguo Fei Ai Za Zhi. 2024 Dec 20;27(12):911-918. doi: 10.3779/j.issn.1009-3419.2024.101.33.
2
[Trend Analysis of Clinical Epidemiological Characteristics of Lung Cancer in Yunnan Cancer Hospital from 2005 to 2014].[2005年至2014年云南省肿瘤医院肺癌临床流行病学特征的趋势分析]
Zhongguo Fei Ai Za Zhi. 2020 Mar 20;23(3):142-149. doi: 10.3779/j.issn.1009-3419.2020.03.05. Epub 2020 Feb 27.
3
[Survival in Lung Cancer among Female Never-smokers in Rural Xuanwei 
and Fuyuan Counties in Eastern Yunnan Province, China].[中国云南省东部宣威和富源县农村女性非吸烟肺癌患者的生存情况]
Zhongguo Fei Ai Za Zhi. 2019 Aug 20;22(8):477-487. doi: 10.3779/j.issn.1009-3419.2019.08.01.
4
[Long-term Survival in Hospitalized Patients with Lung Cancer among Peasants 
in the Coal-producing Area in Eastern Yunnan, China].[中国云南东部产煤区农民肺癌住院患者的长期生存情况]
Zhongguo Fei Ai Za Zhi. 2023 May 20;26(5):359-368. doi: 10.3779/j.issn.1009-3419.2023.101.18.
5
[Clinical epidemiology and histological characteristics of patients with lung cancer in West China Hospital of Sichuan University].四川大学华西医院肺癌患者的临床流行病学及组织学特征
Sichuan Da Xue Xue Bao Yi Xue Ban. 2014 Mar;45(2):309-15.
6
[Analysis of EGFR mutation and clinical features of lung cancer in Yunnan].[云南肺癌表皮生长因子受体(EGFR)突变及临床特征分析]
Zhonghua Zhong Liu Za Zhi. 2020 Sep 23;42(9):729-734. doi: 10.3760/cma.j.cn112152-20200313-00201.
7
[Current status of postoperative pathological diagnosis of lung cancer in China: a multicenter big data study].[中国肺癌术后病理诊断现状:一项多中心大数据研究]
Zhonghua Bing Li Xue Za Zhi. 2021 Aug 8;50(8):882-890. doi: 10.3760/cma.j.cn112151-20210427-00328.
8
Split-lobe resections versus lobectomy for lung carcinoma of the left upper lobe: a pair-matched case-control study of clinical and oncological outcomes.左上叶肺癌的肺叶劈开切除术与肺叶切除术:临床和肿瘤学结局的配对病例对照研究
Eur J Cardiothorac Surg. 2014 Jun;45(6):1034-9. doi: 10.1093/ejcts/ezt514. Epub 2013 Oct 30.
9
[Analysis of Pathological Types and Clinical Epidemiology of 6,058 Patients with Lung Cancer].6058例肺癌患者的病理类型及临床流行病学分析
Zhongguo Fei Ai Za Zhi. 2016 Mar;19(3):129-35. doi: 10.3779/j.issn.1009-3419.2016.03.03.
10
[Driver genes expression and clinical characteristics of targeted therapy in non-small cell lung cancer in Yunnan-Kweichow Plateau].[云贵高原非小细胞肺癌驱动基因表达及靶向治疗的临床特征]
Zhonghua Zhong Liu Za Zhi. 2020 Sep 23;42(9):735-740. doi: 10.3760/cma.j.cn112152-20200323-00248.

本文引用的文献

1
Cancer incidence and mortality in China, 2016.2016年中国癌症的发病率和死亡率
J Natl Cancer Cent. 2022 Feb 27;2(1):1-9. doi: 10.1016/j.jncc.2022.02.002. eCollection 2022 Mar.
2
Lung Cancer Screening in Asia: An Expert Consensus Report.《亚洲肺癌筛查:专家共识报告》
J Thorac Oncol. 2023 Oct;18(10):1303-1322. doi: 10.1016/j.jtho.2023.06.014. Epub 2023 Jun 28.
3
Significant Incidental Findings in the National Lung Screening Trial.国家肺癌筛查试验中的重要偶发发现。
JAMA Intern Med. 2023 Jul 1;183(7):677-684. doi: 10.1001/jamainternmed.2023.1116.
4
Molecular characteristics of lung adenocarcinoma with respect to patient age at diagnosis.肺腺癌在诊断时患者年龄方面的分子特征。
Int J Cancer. 2023 Jul 1;153(1):197-209. doi: 10.1002/ijc.34523. Epub 2023 Apr 3.
5
Cancer statistics, 2023.癌症统计数据,2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
6
Histological types of lung cancer attributable to fine particulate, smoking, and genetic susceptibility.归因于细颗粒物、吸烟和遗传易感性的肺癌组织学类型。
Sci Total Environ. 2023 Feb 1;858(Pt 2):159890. doi: 10.1016/j.scitotenv.2022.159890. Epub 2022 Nov 2.
7
Trends in smoking prevalence in urban and rural China, 2007 to 2018: Findings from 5 consecutive nationally representative cross-sectional surveys.2007 年至 2018 年中国城乡吸烟流行趋势:连续 5 次全国代表性横断面调查的结果。
PLoS Med. 2022 Aug 25;19(8):e1004064. doi: 10.1371/journal.pmed.1004064. eCollection 2022 Aug.
8
The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015.2021 年世卫组织肺肿瘤分类:自 2015 年以来的进展影响。
J Thorac Oncol. 2022 Mar;17(3):362-387. doi: 10.1016/j.jtho.2021.11.003. Epub 2021 Nov 20.
9
Trends and risk factors of lung cancer in China.中国肺癌的趋势与风险因素。
Chin J Cancer Res. 2020 Dec 31;32(6):683-694. doi: 10.21147/j.issn.1000-9604.2020.06.02.
10
Lung Cancer in People's Republic of China.中华人民共和国的肺癌
J Thorac Oncol. 2020 Oct;15(10):1567-1576. doi: 10.1016/j.jtho.2020.04.028.